159 related articles for article (PubMed ID: 15609867)
1. Serum levels of 25-hydroxycholecalciferol and 1,25-dihydroxycholecalciferol in dogs with hypercalcaemia.
Gerber B; Hauser B; Reusch CE
Vet Res Commun; 2004 Nov; 28(8):669-80. PubMed ID: 15609867
[TBL] [Abstract][Full Text] [Related]
2. Serum concentrations of 1,25-dihydroxycholecalciferol and 25-hydroxycholecalciferol in clinically normal dogs and dogs with acute and chronic renal failure.
Gerber B; Hässig M; Reusch CE
Am J Vet Res; 2003 Sep; 64(9):1161-6. PubMed ID: 13677396
[TBL] [Abstract][Full Text] [Related]
3. Evidence for persistent vitamin D 1-alpha-hydroxylation in hemodialysis patients: evolution of serum 1,25-dihydroxycholecalciferol after 6 months of 25-hydroxycholecalciferol treatment.
Jean G; Terrat JC; Vanel T; Hurot JM; Lorriaux C; Mayor B; Chazot C
Nephron Clin Pract; 2008; 110(1):c58-65. PubMed ID: 18724068
[TBL] [Abstract][Full Text] [Related]
4. A comparison of serum ionized calcium concentrations and serum total calcium concentrations in dogs with lymphoma.
Teachout DJ; Taylor SM; Archer FJ
Zentralbl Veterinarmed A; 1997 Jun; 44(4):195-200. PubMed ID: 9270341
[TBL] [Abstract][Full Text] [Related]
5. Circulating vitamin D metabolites and hypercalcaemia of malignancy.
Ralston SH; Cowan RA; Robertson AG; Gardner MD; Boyle IT
Acta Endocrinol (Copenh); 1984 Aug; 106(4):556-63. PubMed ID: 6548074
[TBL] [Abstract][Full Text] [Related]
6. Determinants for serum 1,25-dihydroxycholecalciferol in primary hyperparathyroidism.
Mosekilde L; Charles P; Lindegreen P
Bone Miner; 1989 Mar; 5(3):279-90. PubMed ID: 2720198
[TBL] [Abstract][Full Text] [Related]
7. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
8. Vitamin D and its major metabolites: serum levels after graded oral dosing in healthy men.
Barger-Lux MJ; Heaney RP; Dowell S; Chen TC; Holick MF
Osteoporos Int; 1998; 8(3):222-30. PubMed ID: 9797906
[TBL] [Abstract][Full Text] [Related]
9. Improved cholecalciferol nutrition in rats is noncalcemic, suppresses parathyroid hormone and increases responsiveness to 1, 25-dihydroxycholecalciferol.
Vieth R; Milojevic S; Peltekova V
J Nutr; 2000 Mar; 130(3):578-84. PubMed ID: 10702588
[TBL] [Abstract][Full Text] [Related]
10. Effect of intravenous 1-alpha-hydroxyvitamin D3 on secondary hyperparathyroidism in chronic uremic patients on maintenance hemodialysis.
Brandi L; Daugaard H; Tvedegaard E; Storm T; Olgaard K
Nephron; 1989; 53(3):194-200. PubMed ID: 2797340
[TBL] [Abstract][Full Text] [Related]
11. Intact parathyroid hormone assay and total calcium concentration in the diagnosis of disorders of calcium metabolism in dogs.
Torrance AG; Nachreiner R
J Vet Intern Med; 1989; 3(2):86-9. PubMed ID: 2715961
[TBL] [Abstract][Full Text] [Related]
12. Effect of dietary contents of cholecalciferol, 1 alpha,25-dihydroxycholecalciferol and 24,25-dihydroxycholecalciferol on blood concentrations of 25-hydroxycholecalciferol, 1 alpha,25-dihydroxycholecalciferol, total calcium and eggshell quality.
Tsang CP; Grunder AA
Br Poult Sci; 1993 Dec; 34(5):1021-7. PubMed ID: 8156418
[TBL] [Abstract][Full Text] [Related]
13. Extrarenal synthesis of 1,25-dihydroxyvitamin D: sensitivity to glucocorticoid treatment.
Adami S; Graziani G; Tartarotti D; Cappelli R; Casati S; Cantaluppi A; Braga V; Lo Cascio V
Clin Sci (Lond); 1987 Mar; 72(3):329-34. PubMed ID: 3493110
[TBL] [Abstract][Full Text] [Related]
14. Pseudohyperparathyroidism in the dog.
Osborne CA; Stevens JB
J Am Vet Med Assoc; 1973 Jan; 162(2):125-35. PubMed ID: 4683804
[No Abstract] [Full Text] [Related]
15. Abnormal vitamin D metabolism in Hodgkin's lymphoma.
Davies M; Mawer EB; Hayes ME; Lumb GA
Lancet; 1985 May; 1(8439):1186-8. PubMed ID: 2860388
[TBL] [Abstract][Full Text] [Related]
16. Low utility of serum 25-hydroxyvitamin D
Aly MG; Zhu L; Weimer R; Opelz G; Morath C; Kuon R; Tohamy M; Saadi G; Soliman M; Ibrahim W; Daniel V
Transpl Immunol; 2017 Aug; 43-44():3-10. PubMed ID: 28757397
[TBL] [Abstract][Full Text] [Related]
17. Measurement of vitamin D3 metabolites in smelter workers exposed to lead and cadmium.
Chalkley SR; Richmond J; Barltrop D
Occup Environ Med; 1998 Jul; 55(7):446-52. PubMed ID: 9816377
[TBL] [Abstract][Full Text] [Related]
18. Renal failure, hyperparathyroidism and hypercalcaemia in a dog.
Watson AD; Canfield PJ
Aust Vet J; 1979 Apr; 55(4):177-80. PubMed ID: 464939
[TBL] [Abstract][Full Text] [Related]
19. A possible direct effect of 24,25-dihydroxycholecalciferol on the parathyroid gland in patients with chronic renal failure.
Christiansen C; Rødbro P; Naestoft J; Christensen MS
Clin Endocrinol (Oxf); 1981 Sep; 15(3):237-42. PubMed ID: 6273028
[TBL] [Abstract][Full Text] [Related]
20. Lack of effect of 24,25-dihydroxyvitamin D3 administration on parameters of calcium metabolism.
Harvey JA; Zerwekh JE; Sakhaee K; Pak CY
J Clin Endocrinol Metab; 1989 Aug; 69(2):467-9. PubMed ID: 2787802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
